Filter
2405
Filtered Results: 2405
Text search:
vaccine
coverage
Featured
Recommendations
216
New Publications
748
Language
Document type
No document type
1232
Studies & Reports
488
Guidelines
271
Strategic & Response Plan
153
Manuals
110
Fact sheets
61
Situation Updates
43
Training Material
20
Resource Platforms
12
Infographics
9
Online Courses
3
Brochures
2
Videos
1
Countries / Regions
Global
127
India
107
Kenya
82
Nigeria
64
Liberia
61
Sierra Leone
57
Ethiopia
56
Africa
51
Nepal
48
South Africa
48
Latin America and the Carribbean
44
Uganda
44
Malawi
42
Bangladesh
40
Congo, Democratic Republic of
37
Western and Central Europe
36
Myanmar / Burma
35
Zambia
34
Ghana
33
Rwanda
33
Tanzania
33
Syria
28
Ukraine
27
Philippines
24
Lesotho
22
Zimbabwe
21
Senegal
20
South–East Asia Region
20
Pakistan
20
East and Southern Africa
19
South Sudan
19
Guinea
18
Mozambique
17
Eastern Europe
17
Namibia
17
Yemen
17
Brazil
16
Asia
15
West and Central Africa
15
Indonesia
14
Venezuela
13
Cambodia
12
Middle East and North Africa
12
Afghanistan
11
Haiti
11
Botswana
11
Cameroon
10
Burkina Faso
10
Lebanon
10
Sudan
10
Western Pacific Region
9
Somalia
9
Colombia
8
Eastern Europe and Central Asia
7
Central African Republic
7
Germany
6
Russia
6
Mali
6
China
5
Niger
5
Peru
5
Jordan
5
Angola
5
Eswatini/ Swaziland
5
Chile
4
Argentina
4
Moldova
4
Iraq
4
Thailand
3
Mexico
3
Benin
3
Laos
3
Burundi
3
Paraguay
3
Côte d’Ivoire / Ivory Coast
3
Bolivia
3
Papua New Guinea
3
Chad
3
Ecuador
3
Tajikistan
2
El Salvador
2
Turkey
2
Togo
2
Iran
2
Albania
2
Malaysia
2
Guinea-Bissau
2
Japan
2
Spain
2
Egypt
2
Palestine
2
Georgia
2
Honduras
2
Libya
2
Madagascar
2
North Macedonia
1
Timor Leste/ East Timor
1
Canada
1
Kyrgyzstan
1
Congo-Brazzaville
1
Morocco
1
Qatar
1
Bulgaria
1
USA
1
Saudi Arabia
1
North America
1
Gabon
1
Uruguay
1
Turkmenistan
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Southern Africa
1
Vietnam
1
Nicaragua
1
Sri Lanka
1
Djibouti
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1081
Clinical Guidelines
195
Public Health
147
Women & Child Health
128
Key Resources
76
Pharmacy & Technologies
17
Capacity Building
15
Annual Report MEDBOX
1
Toolboxes
COVID-19
348
HIV
146
Rapid Response
105
TB
100
AMR
93
Conflict
72
Global Health Education
66
Ebola
62
NTDs
54
Health Financing Toolbox
53
Polio
47
Refugee
39
Caregiver
38
Planetary Health
38
Pharmacy
32
Mental Health
29
Natural Hazards
27
Cholera
22
NCDs
16
Disability
15
Zika
8
Specific Hazards
4
Health Financing
2
Typhoon
2
South Sudan
1
The position papers are intended for use by national public health officials and managers of immunization programmes. They may also be of interest to international funding agencies, vaccine advisory groups, vaccine manufacturers, health professionals, researchers, the scientific media and the genera...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
Rabies is fatal, vaccine-preventable disease responsible for an estimated 59,000 human deaths each year. Most cases are transmitted by dogs, and most deaths occur in underserved populations in Africa and Asia. Approximately 40% of deaths occur in children.
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr...
The new five-year agenda of WHO in Africa, The Africa Health Transformation Programme, 2015–2020: a vision for universal health coverage, is the strategic framework that will guide WHO’s contribution to the emerging sustainable development platform in Africa. It articulates a vision for health a...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
An example of integration of research into epidemic response.
The report summarizes key global health expenditure patterns and trends, and illustrates the potential of the new database to inform thinking about financing reforms to progress towards UHC, and also raises issues for further research. It analyses the following areas:
Orientations pour faire face à une infodémie mondiale et favoriser la demande de vaccination
Décembre 2020
La désinformation menace le succès des programmes de vaccination dans le monde entier. Ce guide vise à aider les organisations à faire face à l'infodémie mondiale par l'élaboration ...
The WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination is intended to offer guidance on the prioritization of groups for vaccination when vaccine supply is limited. It provides a values foundation for the objectives of COVID-19 vaccination programmes and links t...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
